Physician profile
Vasantha Agusala
NPI 1619006228
$1,536.73
in general payments reported to CMS, 2019-2025
9 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $116 · 2021: $438 · 2022: $91.92 · 2023: $238 · 2024: $422 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $616.37 | 2019-2024 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $396.86 | 2019-2025 | Farxiga |
| Amgen INC. | $266.43 | 2023-2025 | Repatha, Repatha |
| Lilly USA, LLC | $136.63 | 2023-2024 | Jardiance, Synjardy, Zepbound |
| Abbott Laboratories | $44.39 | 2023 | Freestyle Libre, Proclaim |
| Pfizer INC. | $26.43 | 2024 | |
| Novartis Pharmaceuticals Corporation | $20.01 | 2024 | |
| Amarin Pharma, INC. | $16.08 | 2020 | |
| Esperion Therapeutics, INC. | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasantha Agusala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.